Rosati E, Giuseppe G, Mezza T, Ferraro P
J Nephrol. 2024; 37(8):2139-2150.
PMID: 39167349
PMC: 11649737.
DOI: 10.1007/s40620-024-02048-w.
Di Piazza E, Todi L, Giuseppe G, Soldovieri L, Ciccarelli G, Brunetti M
Int J Mol Sci. 2024; 25(11).
PMID: 38892122
PMC: 11172646.
DOI: 10.3390/ijms25115936.
van Allen K, Gang N, Hoyeck M, Perera I, Zhang D, Atlas E
Islets. 2024; 16(1):2361996.
PMID: 38833523
PMC: 11152096.
DOI: 10.1080/19382014.2024.2361996.
Sajiir H, Wong K, Muller A, Keshvari S, Burr L, Aiello E
Nat Commun. 2024; 15(1):4527.
PMID: 38811550
PMC: 11137127.
DOI: 10.1038/s41467-024-48320-2.
Durrer C, Islam H, Cen H, Garzon M, Lyu X, McKelvey S
Nutr Metab (Lond). 2024; 21(1):29.
PMID: 38797835
PMC: 11129411.
DOI: 10.1186/s12986-024-00807-x.
Hailey-Hailey Disease is Associated with Diabetes: A Population-based Cohort Study, Clinical Cohort Study, and Pedigree Analysis.
Curman P, Jebril W, Evans-Molina C, Bachar-Wikstrom E, Larsson H, Cederlof M
Acta Derm Venereol. 2023; 103:adv10436.
PMID: 38014829
PMC: 10695124.
DOI: 10.2340/actadv.v103.10436.
High proinsulin:C-peptide ratio identifies individuals with stage 2 type 1 diabetes at high risk for progression to clinical diagnosis and responses to teplizumab treatment.
Sims E, Geyer S, Long S, Herold K
Diabetologia. 2023; 66(12):2283-2291.
PMID: 37667106
PMC: 10914155.
DOI: 10.1007/s00125-023-06003-5.
Effects of PCSK9 inhibition on glucose metabolism and β-cell function in humans: a pilot study.
Moffa S, Mezza T, Ferraro P, Giuseppe G, Cefalo C, Cinti F
Front Endocrinol (Lausanne). 2023; 14:1124116.
PMID: 37324254
PMC: 10266211.
DOI: 10.3389/fendo.2023.1124116.
Loci for insulin processing and secretion provide insight into type 2 diabetes risk.
Broadaway K, Yin X, Williamson A, Parsons V, Wilson E, Moxley A
Am J Hum Genet. 2023; 110(2):284-299.
PMID: 36693378
PMC: 9943750.
DOI: 10.1016/j.ajhg.2023.01.002.
High-throughput genetic clustering of type 2 diabetes loci reveals heterogeneous mechanistic pathways of metabolic disease.
Kim H, Westerman K, Smith K, Chiou J, Cole J, Majarian T
Diabetologia. 2022; 66(3):495-507.
PMID: 36538063
PMC: 10108373.
DOI: 10.1007/s00125-022-05848-6.
Every islet matters: improving the impact of human islet research.
Gloyn A, Ibberson M, Marchetti P, Powers A, Rorsman P, Sander M
Nat Metab. 2022; 4(8):970-977.
PMID: 35953581
PMC: 11135339.
DOI: 10.1038/s42255-022-00607-8.
Link between Insulin Resistance and Obesity-From Diagnosis to Treatment.
Golacki J, Matuszek M, Matyjaszek-Matuszek B
Diagnostics (Basel). 2022; 12(7).
PMID: 35885586
PMC: 9321808.
DOI: 10.3390/diagnostics12071681.
Effects of Sodium-Glucose Co-Transporter-2 Inhibitors on Pancreatic β-Cell Mass and Function.
Nakamura A
Int J Mol Sci. 2022; 23(9).
PMID: 35563495
PMC: 9105075.
DOI: 10.3390/ijms23095104.
Digital Health Coaching for Type 2 Diabetes: Randomized Controlled Trial of Healthy at Home.
Azelton K, Crowley A, Vence N, Underwood K, Morris G, Kelly J
Front Digit Health. 2021; 3:764735.
PMID: 34901926
PMC: 8655126.
DOI: 10.3389/fdgth.2021.764735.
Inside the Insulin Secretory Granule.
Germanos M, Gao A, Taper M, Yau B, Kebede M
Metabolites. 2021; 11(8).
PMID: 34436456
PMC: 8401130.
DOI: 10.3390/metabo11080515.
The β Cell in Diabetes: Integrating Biomarkers With Functional Measures.
Kahn S, Chen Y, Esser N, Taylor A, van Raalte D, Zraika S
Endocr Rev. 2021; 42(5):528-583.
PMID: 34180979
PMC: 9115372.
DOI: 10.1210/endrev/bnab021.
The miR-200-Zeb1 axis regulates key aspects of β-cell function and survival in vivo.
Title A, Silva P, Godbersen S, Hasenohrl L, Stoffel M
Mol Metab. 2021; 53:101267.
PMID: 34116231
PMC: 8258987.
DOI: 10.1016/j.molmet.2021.101267.
Altered β-Cell Prohormone Processing and Secretion in Type 1 Diabetes.
Rodriguez-Calvo T, Chen Y, Verchere C, Haataja L, Arvan P, Leete P
Diabetes. 2021; 70(5):1038-1050.
PMID: 33947721
PMC: 8173804.
DOI: 10.2337/dbi20-0034.
Pancreaticoduodenectomy model demonstrates a fundamental role of dysfunctional β cells in predicting diabetes.
Mezza T, Ferraro P, Giuseppe G, Moffa S, Cefalo C, Cinti F
J Clin Invest. 2021; 131(12).
PMID: 33905373
PMC: 8203447.
DOI: 10.1172/JCI146788.
Limitations of the fasting proinsulin to insulin ratio as a measure of β-cell health in people with and without impaired glucose tolerance.
Egan A, Laurenti M, Hurtado Andrade M, Dalla Man C, Cobelli C, Bailey K
Eur J Clin Invest. 2020; 51(6):e13469.
PMID: 33289929
PMC: 8169515.
DOI: 10.1111/eci.13469.